Free
All Subscriber Access
BiQ: PRGN-2012 vs INO-3107: Two Strong Contenders (PGEN, INO)
BiQ: An Update on MeiraGTx (MGTX)
BiQ: Jazz Pharmaceuticals Buys Chimerix (CMRX)
BiQ: Removing the Watch List Feature
BiQ: Recap for Week Ending February 28, 2025 (Free)
BiQ: Assessing Iovance's 2024 Earnings and 2025 Guidance (IOVA)
BiQ: FDA Grants Priority Review to PRGN-2012 (PGEN)
BiQ: Adding Nuvation Bio to the Active Portfolio (NUVB)
BiQ: Weekly Recap for February 23, 2025 (Free)
BiQ: Adding Chimerix to Active Coverage (CMRX)